Medicine

M. Doi, N. Hirata, Toshiyasu Suzuki, H. Morisaki, H. Morimatsu, A. Sakamoto

2020.4.17Journal of Anesthesia

DOI: 10.1007/s00540-020-02776-w

tlooto Summary

Both induction regimens were equally efficacious and safe in surgical patients ASA Class III, and a significantly shorter time to LoC was observed with the higher remimazolam dosage.

Abstract

Abstract is not available.

Citation format

DOI, M., et al. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA class III): Results of a multicenter, randomized, double-blind, parallel-group comparative trial. Journal of Anesthesia, 2020: 1–11.